Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.32B | 1.29B | 1.11B | 905.18M | 698.99M | 502.03M | Gross Profit |
193.67M | 178.80M | 131.02M | 122.19M | 104.35M | 81.90M | EBIT |
-4.54M | -9.51M | -40.66M | -42.75M | -35.02M | -4.35M | EBITDA |
26.39M | 21.33M | -20.48M | -29.01M | -23.25M | 2.73M | Net Income Common Stockholders |
-4.26M | -9.63M | -44.69M | -44.67M | -35.53M | -5.84M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
321.82M | 307.38M | 277.17M | 222.41M | 213.41M | 229.74M | Total Assets |
837.16M | 806.85M | 782.95M | 671.63M | 562.58M | 498.25M | Total Debt |
128.88M | 128.89M | 128.93M | 69.46M | 0.00 | 0.00 | Net Debt |
-37.43M | -31.41M | -18.57M | 3.85M | -87.40M | -139.88M | Total Liabilities |
503.49M | 483.58M | 479.23M | 366.33M | 230.38M | 158.31M | Stockholders Equity |
333.67M | 323.27M | 303.72M | 305.30M | 332.20M | 339.94M |
Cash Flow | Free Cash Flow | ||||
53.24M | 38.57M | 358.00K | -25.09M | -4.90M | 14.09M | Operating Cash Flow |
61.82M | 48.29M | 18.64M | -8.00M | 7.46M | 21.54M | Investing Cash Flow |
-19.69M | -13.46M | 7.64M | -67.52M | -51.91M | -76.75M | Financing Cash Flow |
-4.13M | -3.96M | 59.13M | 60.74M | -1.13M | 170.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $1.17B | 11.79 | 9.84% | 2.51% | -0.88% | -12.63% | |
72 Outperform | $907.37M | 19.20 | 16.89% | 3.16% | -2.51% | -22.68% | |
67 Neutral | $2.00B | ― | -1.34% | ― | 14.08% | 84.28% | |
65 Neutral | $856.43M | 18.57 | 11.12% | 1.05% | 15.76% | 105.98% | |
64 Neutral | $12.79B | 9.71 | 7.54% | 16971.00% | 12.07% | -7.53% | |
55 Neutral | $619.62M | ― | -15.58% | ― | 77.44% | 85.53% | |
44 Neutral | $365.38M | 72.67 | -2.23% | ― | 10.50% | -92.02% |
On May 15, 2025, the New York Department of Financial Services approved a $26 million extraordinary dividend to be paid to Trupanion, Inc. by its wholly-owned subsidiary, American Pet Insurance Company. This approval could enhance Trupanion’s financial flexibility and potentially improve its market positioning, benefiting stakeholders by possibly increasing shareholder value.
The most recent analyst rating on (TRUP) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Trupanion stock, see the TRUP Stock Forecast page.